Hakutulokset - Shannon, Jennifer

The C-Terminal Domain of the Bordetella pertussis Autotransporter BrkA Forms a Pore in Lipid Bilayer Membranes Tekijä Shannon, Jennifer L., Fernandez, Rachel C.

Hae kokoteksti Hae kokoteksti

Specialist physicians’ referral behavior regarding preimplantation genetic testing for single-gene disorders: Is there room to grow? Tekijä Capelouto, Sarah, Evans, Melanie, Shannon, Jennifer, Jetelina, Katelyn, Bukulmez, Orhan, Carr, Bruce

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Feasibility and Impact of Integrating an Artificial Intelligence–Based Diagnosis Aid for Autism Into the Extension for Community Health Outcomes Autism Primary Care Model: Protocol... Tekijä Sohl, Kristin, Kilian, Rachel, Brewer Curran, Alicia, Mahurin, Melissa, Nanclares-Nogués, Valeria, Liu-Mayo, Stuart, Salomon, Carmela, Shannon, Jennifer, Taraman, Sharief

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Relationship between cardiovascular risk factors and biomarkers with necrotic core and atheroma size: a serial intravascular ultrasound radiofrequency data analysis Tekijä García-García, Héctor M., Klauss, Volker, Gonzalo, Nieves, Garg, Scot, Onuma, Yoshinobu, Hamm, Christian W., Wijns, William, Shannon, Jennifer, Serruys, Patrick W.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial Tekijä Tebbutt, Niall C, Price, Timothy J, Ferraro, Danielle A, Wong, Nicole, Veillard, Anne-Sophie, Hall, Merryn, Sjoquist, Katrin M, Pavlakis, Nick, Strickland, Andrew, Varma, Suresh C, Cooray, Prasad, Young, Rosemary, Underhill, Craig, Shannon, Jennifer A, Ganju, Vinod, Gebski, Val

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Evaluation of an artificial intelligence-based medical device for diagnosis of autism spectrum disorder Tekijä Megerian, Jonathan T., Dey, Sangeeta, Melmed, Raun D., Coury, Daniel L., Lerner, Marc, Nicholls, Christopher J., Sohl, Kristin, Rouhbakhsh, Rambod, Narasimhan, Anandhi, Romain, Jonathan, Golla, Sailaja, Shareef, Safiullah, Ostrovsky, Andrey, Shannon, Jennifer, Kraft, Colleen, Liu-Mayo, Stuart, Abbas, Halim, Gal-Szabo, Diana E., Wall, Dennis P., Taraman, Sharief

Hae kokoteksti Hae kokoteksti Hae kokoteksti

MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a... Tekijä Siu, Ho Wai Derrick, Tebbutt, Niall, Chantrill, Lorraine, Karapetis, Chris, Steer, Christopher, Wilson, Kate, Espinoza, David, Bailey, Lisa, Yip, Sonia, Cuff, Jeff, Pavlakis, Nick, Thavaneswaran, Subotheni, Briscoe, Karen, Srivastav, Ratnesh, Shannon, Jennifer, Segelov, Eva, Tie, Jeannie, Caird, Susan, Francesconi, Alessandra, Price, Timothy, Wuttke, Melanie, Ladwa, Rahul, Sjoquist, Katrin, Burge, Matthew

Hae kokoteksti Hae kokoteksti Hae kokoteksti

hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA Tekijä Aughton, Karen, Elander, Nils O., Evans, Anthony, Jackson, Richard, Campbell, Fiona, Costello, Eithne, Halloran, Christopher M., Mackey, John R., Scarfe, Andrew G., Valle, Juan W., Carter, Ross, Cunningham, David, Tebbutt, Niall C., Goldstein, David, Shannon, Jennifer, Glimelius, Bengt, Hackert, Thilo, Charnley, Richard M., Anthoney, Alan, Lerch, Markus M., Mayerle, Julia, Palmer, Daniel H., Büchler, Markus W., Ghaneh, Paula, Neoptolemos, John P., Greenhalf, William

Hae kokoteksti Hae kokoteksti Hae kokoteksti